´ë·®±¸¸ÅȨ >
ÀÚ¿¬°ú °úÇÐ
>
ÀÇÇÐ/»ý¸íÀÇ ÀÌÇØ
>
ÀÇÇÐÀ̾߱â

¾à±¹¿¡¼­ ½áº» ¼¼ ¹ø° ¾àÀ̾߱â
Á¤°¡ 25,000¿ø
ÆǸŰ¡ 25,000¿ø (0% , 0¿ø)
I-Æ÷ÀÎÆ® 750P Àû¸³(3%)
ÆǸŻóÅ ÆǸÅÁß
ºÐ·ù ÀÇÇÐÀ̾߱â
ÀúÀÚ ¹ÚÁ¤¿Ï , ¹ÚÁ¤¿Ï
ÃâÆÇ»ç/¹ßÇàÀÏ Âü¾à»ç / 2019.04.30
ÆäÀÌÁö ¼ö 267 page
ISBN 9791196168032
»óÇ°ÄÚµå 307645604
°¡¿ëÀç°í Àç°íºÎÁ·À¸·Î ÃâÆÇ»ç ¹ßÁÖ ¿¹Á¤ÀÔ´Ï´Ù.
 
ÁÖ¹®¼ö·® :
´ë·®±¸¸Å Àü¹® ÀÎÅÍÆÄÅ© ´ë·®ÁÖ¹® ½Ã½ºÅÛÀ» ÀÌ¿ëÇÏ½Ã¸é °ßÀû¿¡¼­ºÎÅÍ ÇàÁ¤¼­·ù±îÁö Æí¸®ÇÏ°Ô ¼­ºñ½º¸¦ ¹ÞÀ¸½Ç ¼ö ÀÖ½À´Ï´Ù.
µµ¼­¸¦ °ßÀûÇÔ¿¡ ´ãÀ¸½Ã°í ½Ç½Ã°£ °ßÀûÀ» ¹ÞÀ¸½Ã¸é ±â´Ù¸®½Ç ÇÊ¿ä¾øÀÌ ÇÒÀιÞÀ¸½Ç ¼ö ÀÖ´Â °¡°ÝÀ» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
¸ÅÁÖ ¹ß¼ÛÇØ µå¸®´Â ÀÎÅÍÆÄÅ©ÀÇ ½Å°£¾È³» Á¤º¸¸¦ ¹Þ¾Æº¸½Ã¸é »óÇ°ÀÇ ¼±Á¤À» ´õ¿í Æí¸®ÇÏ°Ô ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.

 ´ë·®±¸¸ÅȨ  > ÀÚ¿¬°ú °úÇÐ  > ÀÇÇÐ/»ý¸íÀÇ ÀÌÇØ  > ÀÇÇÐÀ̾߱â

¾à±¹¿¡¼­ ½á º» ¾à À̾߱⠼¼Æ® 120,000¿ø (0%)
¾à±¹¿¡¼­ ½áº» ¼¼ ¹ø° ¾àÀ̾߱â 25,000¿ø (0%)
¾à±¹¿¡¼­ ½áº» µÎ ¹ø° ¾àÀ̾߱â 25,000¿ø (0%)
¾à±¹¿¡¼­ ½áº» ù ¹ø° ¾àÀ̾߱â 25,000¿ø (0%)
        
 

 
¸ñÂ÷
ÃßõÀÇ ±Û Ã¥ ¸Ó¸®¿¡ 123 Antihistamine 124 Mast cell stabilizers 125 ºñ°­³» ½ºÅ×·ÎÀ̵åÁ¦ intranasal corticosteroids 126 Type 2 histamine receptor antagonist 127 Cyanocobalamine 128 °³·®½Å¾à (Incrementally Modified Drug£ºIMD) 129 Radiopharmaceuticals (¹æ»ç¼º ÀǾàÇ°) 130 Advanced dressing 131 DNA virus, RNA virus 132 AÇü °£¿° 133 BÇü °£¿° 134 CÇü °£¿° 135 Lithium carbonate 136 Selective Estrogen Receptor Modulator(SERMs) 137 Aromatase inhibitor 138 Progestin °ü·Ã¾à¹° 139 Àü¸³¼±¾Ï °ü·Ã ¾à¹° 140 Prostaglandin °ü·Ã ¾à¹° 141 Praziquantel, Albendazole ±×¸®°í Niclosamide 142 Blood coagulation factor 143 Vitamin K 144 Tranexamic acid(µµ¶õ»ç¹Î) 145 Heparin 146 Warfarin 147 New Oral Anti Coagulant (NOAC) 148 ¼­¹æÇü Á¦Á¦ 149 Gargle ¹× ¼¼Á¤Á¦ 150 Alkylating antineoplastic agent 151 Platinum Ç×¾ÏÁ¦ 152 Antimetabolites °ü·Ã ¾à¹° 153 Antitumor Antibiotics 154 ½Ä¹°À» ÀÌ¿ëÇÑ Ç×¾ÏÁ¦ 155 ±âŸ Ç×¾ÏÁ¦ 156 Mistletoe(¹Ì½½Åä) 157 P-glycoprotein ¾à¹° ¼ö¼Û´Ü¹é 158 Salicylic acid¿Í ¿°Áõ¼º ÀåÁúȯ ¾à¹° 159 º¯ºñ °ü·Ã ¾à¹° 160 Alpha adrenergic receptor 161 Beta È¿ÇöÁ¦ 162 Carotenoids 163 Flavonoids 164 Flavonoid ÀǾàÇ° 165 Á¤À¯(ïñêú, essential oil)¾à¹° 166 À̸§ÀÌ È¿´ÉÀ» ¸»ÇÏ´Â º»ÃÊ(Üâõ®) 167 ¾¦°ú ¾î¼ºÃÊ(åàá£õ®) 168 ¸¶(Ø«), õ(ô¸)ÀÌ µé¾î°£ º»ÃÊ(Üâõ®) 169 Çà(úº)°ú ñÓ(´ë³ª¹«) 170 ¶¥ Áö(ò¢)°¡ µé¾î°£ º»ÃÊ(Üâõ®) 171 °­ÀåÁ¦ ¸¶(ߣå·), »ê¼öÀ¯ 172 Çâ(úÅ) 173 ÀÚÇÏ°Å(í¹ùÁËç) 174 ¸ÀÀ» Ç¥ÇöÇÑ º»ÃÊ(Üâõ®) 175 ¸ð½ÀÀÌ °ð À̸§ÀÎ º»ÃÊ(Üâõ®) 176 19±Ý º»ÃÊ(Üâõ®) INDEX

ÀúÀÚ
¹ÚÁ¤¿Ï
ÀλýÀÇ ´ëºÎºÐÀ» ¾à»ç·Î È°µ¿ÇÏ´Ù°¡ µÚ´Ê°Ô ±×¸²Ã¥ ¼¼°è¿¡ ¹ßÀ» µé¿©³õ¾Ò´Ù. ±×¸²°ú À̾߱Ⱑ ÁÁ¾Æ¼­, ¾ÆÀ̵é°ú ÇÔ²² ³ª´­ ¼ö ÀÖ´Â °Ô ÁÁ¾Æ¼­ ±×¸²Ã¥ ÀÛ°¡°¡ µÇ¾ú´Ù. ù Ã¥ [¾Æ±â Áã°¡ ÀáÀÚ·¯ °¡¿ä]·Î 2011³â º¼·Î³Ä ±¹Á¦ ¾î¸°ÀÌ µµ¼­Àü¿¡¼­ ¡®¿ÃÇØÀÇ ÀÏ·¯½ºÆ®·¹ÀÌÅÍ¡¯·Î ¼±Á¤µÇ¾ú´Ù. À̹ø [½£ ¼Ó ¾à±¹ ³îÀÌ]´Â µþ°ú 6°³¿ù µÈ ¿Ü¼Õ³à¸¦ »ý°¢Çϸç ÀÛ¾÷Çß´Ù. ÀÛÇ°À¸·Î ±×¸²Ã¥ [¾ö¸¶ ¾îµð ÀÖ¾î¿ä?]¿Í [À¯¸® ¾¾¾Ñ]ÀÌ ÀÖ´Ù.
   ¾Æ±â Áã°¡ ÀáÀÚ·¯ °¡¿ä | ¹ÚÁ¤¿Ï | ½Ã°øÁִϾî
   ½£ ¼Ó ¾à±¹ ³îÀÌ | ¹ÚÁ¤¿Ï | ½Ã°øÁִϾî
   ¾à±¹¿¡¼­ ¾Ë·ÁÁØ ±Ã±ÝÇÑ ¾à À̾߱â | ¹ÚÁ¤¿Ï | Á¶À±Ä¿¹Â´ÏÄÉÀ̼Ç
   ¾à±¹¿¡¼­ ½áº» ù ¹ø° ¾àÀ̾߱â | ¹ÚÁ¤¿Ï | Âü¾à»ç
   ¾à±¹¿¡¼­ ½áº» µÎ ¹ø° ¾àÀ̾߱â | ¹ÚÁ¤¿Ï | Âü¾à»ç
¹ÚÁ¤¿Ï
´ëÇб³¿¡¼­ ¾àÇÐÀ» °øºÎÇÏ°í ¾à»ç°¡ µÇ¾ú´Ù. ±×·¯³ª ±×¸²À» ±×¸®°í ½ÍÀº ²ÞÀ» ¹ö¸± ¼ö ¾ø¾î ´ëÇпø¿¡ ÁøÇÐÇØ ±×¸² °øºÎ¸¦ ½ÃÀÛÇß°í, ±×¸²Ã¥À» ¸¸µé°í ½Í¾î¼­ ±×¸²Ã¥ ¿öÅ©¼ó¿¡ Âü¿©Çß´Ù. '¾Æ±â Áã°¡ ÀáÀÚ·¯ °¡¿ä'´Â ¼¼»ó¿¡ ¼±º¸À̴ ù ±×¸²Ã¥À̸ç, ÀÌ ±×¸²Ã¥À» ¸¸µé¸é¼­ ¿¬½ÀÇÏ°í ÁغñÇß´ø ±×¸²À» 2011³â º¼·Î³Ä ±¹Á¦ ¾î¸°ÀÌ µµ¼­°üÀü¿¡ ÃâÇ°ÇÏ¿© '¿ÃÇØÀÇ ÀÏ·¯½ºÆ®·¹ÀÌÅÍ'¿¡ ¼±Á¤µÇ¾ú´Ù. µ¿ÆÇÈ­¿Í ÄݶóÁÖ¸¦ È¥ÇÕÇØ Àá ¸ø ÀÌ·ç´Â ¿©ÀÚ¾ÆÀÌÀÇ ¿¹¹ÎÇÏ°í ¼¶¼¼ÇÑ ¸¶À½, Àû¸·ÇÏ°í ÀÜÀÜÇÑ ÇѹãÀÇ Á¤°æÀ» ¾Æ¸§´ä°Ô Ç¥ÇöÇØ ³Â´Ù. ¾Æ¸§´ä°í °¨µ¿À» ÁÖ´Â ±×¸²Ã¥À» ¸¸µé±â À§ÇØ Áö±Ýµµ À̾߱Ⱑ ÀÖ´Â ±×¸²À» ±×¸®°í ÀÖ´Ù.
   ¾Æ±â Áã°¡ ÀáÀÚ·¯ °¡¿ä | ¹ÚÁ¤¿Ï | ½Ã°øÁִϾî
   ½£ ¼Ó ¾à±¹ ³îÀÌ | ¹ÚÁ¤¿Ï | ½Ã°øÁִϾî
   ¾à±¹¿¡¼­ ¾Ë·ÁÁØ ±Ã±ÝÇÑ ¾à À̾߱â | ¹ÚÁ¤¿Ï | Á¶À±Ä¿¹Â´ÏÄÉÀ̼Ç
   ¾à±¹¿¡¼­ ½áº» ù ¹ø° ¾àÀ̾߱â | ¹ÚÁ¤¿Ï | Âü¾à»ç
   ¾à±¹¿¡¼­ ½áº» µÎ ¹ø° ¾àÀ̾߱â | ¹ÚÁ¤¿Ï | Âü¾à»ç

ÀÌ ÃâÆÇ»çÀÇ °ü·Ã»óÇ°
¾à±¹¿¡¼­ ½á º» ¾à À̾߱⠼¼Æ® | Âü¾à»ç
¾à»çµéÀÌ ´äÇÏ´Â ½ºÆ÷Ã÷ ¿µ¾ç QA | Á¤»ó¿ø | Âü¾à»ç
¾à±¹¿¡¼­ ½áº» ´Ù¼¸ ¹ø° ¾à À̾߱â | ¹ÚÁ¤¿Ï | Âü¾à»ç
ÇÑ ±ÇÀ¸·Î ³¡³»´Â ¾àÇнûç(2022) | ¼ÕÁøÈÆ,°ûÇý¹Î,ÀÌ»ó°ï,±è¹ÎÁö,±èÁöÀº ¿Ü | Âü¾à»ç
¾à±¹¿¡¼­ ½áº» ³× ¹ø° ¾àÀ̾߱â | ¹ÚÁ¤¿Ï | Âü¾à»ç

ÀÌ ºÐ¾ß ½Å°£ °ü·Ã»óÇ°
ÀÇ·á±â±â ÀÎÇã°¡(2024) | ±èÁ¾Çö,±è¸í±³ | À§Áî´ýÇÃ
°Ç°­°ËÁø°ü¸® | ±èȸâ | º¸¹®°¢
(set)ÃÖ½ÅÁö¿ª»çȸº¸°Ç°£È£ÇÐ1,2(ÃÖÀº¼÷¿Ü) | ¼ö¹®»ç
ÇÁ¼Á³ëÆ® ±âº»Æí | µå¸²³Î½º
¾Ë±â½¬¿î °Ç°­º¸Çè·Ð | È«º¸°æ | ¸Þµð½Ã¾ð
 
µµ¼­¸¦ ±¸ÀÔÇϽŠ°í°´ ¿©·¯ºÐµéÀÇ ¼­ÆòÀÔ´Ï´Ù.
ÀÚÀ¯·Î¿î ÀÇ°ß ±³È¯ÀÌ °¡´ÉÇÕ´Ï´Ù¸¸, ¼­ÆòÀÇ ¼º°Ý¿¡ ¸ÂÁö ¾Ê´Â ±ÛÀº »èÁ¦µÉ ¼ö ÀÖ½À´Ï´Ù.

µî·ÏµÈ ¼­ÆòÁß ºÐ¾ß¿Í »ó°ü¾øÀÌ ¸ÅÁÖ ¸ñ¿äÀÏ 5ÆíÀÇ ¿ì¼öÀÛÀ» ¼±Á¤ÇÏ¿©, S-Money 3¸¸¿øÀ» Àû¸³Çص帳´Ï´Ù.
ÃÑ 0°³ÀÇ ¼­ÆòÀÌ ÀÖ½À´Ï´Ù.